PFE Operating Income Growth
Pfizer · Operating Income Growth
PFE Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-15.44%period ending
PFE TTM Operating Income YoY % (7.45% → -15.44%)
Year-over-year change
High-resolution chart · PNG
PFE operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| -15.4351% | |
| -13.6718% | |
| -9.8885% | |
| 72.2764% | |
| 771.0005% | |
| 551.117% | |
| 259.3665% | |
| -10.8543% | |
| -90.9936% | |
| -92.3844% | |
| -87.4675% | |
| -68.3672% | |
| -29.2093% | |
| 28.1512% | |
| 74.2499% | |
| 84.7406% | |
| 139.2405% | |
| 151.8943% | |
| 141.5781% | |
| 91.6527% | |
| 28.9445% | |
| -15.5425% | |
| -35.983% | |
| -33.714% | |
| -30.4359% | |
| -19.0479% | |
| -7.5154% | |
| 5.7622% | |
| 9.5123% | |
| 9.9888% | |
| 6.0598% | |
| 0.2629% | |
| 1.6002% | |
| 0.8329% | |
| 2.4345% | |
| 5.0211% | |
| 1.59% | |
| 1.8328% | |
| 9.5104% | |
| 7.1473% | |
| 11.5929% | |
| 7.7024% | |
| 1.367% | |
| -8.6227% | |
| -13.9767% | |
| -12.6867% | |
| -22.552% | |
| -14.1409% | |
| -10.9635% | |
| -15.6066% | |
| -9.7636% | |
| -12.3514% | |
| -15.8772% | |
| -5.8283% | |
| -0.3686% | |
| 14.9133% | |
| 45.1555% | |
| 31.832% | |
| 32.5191% | |
| 9.9432% | |
| -20.2066% | |
| -7.6455% | |
| -12.2577% | |
| -9.1222% | |
| 16.4259% | |
| 12.4761% | |
| 23.8099% | |
| 46.0717% | |
| 53.1174% | |
| 52.382% | |
| 22.1459% | |
| 7.5311% | |
| -29.4632% | |
| -39.3748% | |
| -28.3714% | |
| -33.0597% | |
| -12.6695% | |
| -3.2862% | |
| -3.3036% | |
| -3.1729% | |
| -8.0134% | |
| -9.9864% | |
| -16.3743% | |
| 0.2258% | |
| 18.0319% | |
| 36.3035% | |
| 65.4766% | |
| 40.9264% | |
| 18.6476% | |
| -1.5247% | |
| -12.1538% | |
| -3.448% | |
| 4.816% | |
| 10.8051% | |
| 11.844% | |
| 11.4843% | |
| 14.0476% | |
| 25.719% | |
| 42.5084% | |
| 56.6086% |